WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) provided a statement of support for the Prescription Drug User Fee Act (PDUFA) V recommendations during a public meeting hosted by the U.S. Food and Drug Administration (FDA) today.
